Skip to content
Home
About
About Us
R&D Team
Quality System
Honors & Certifications
Patent & Technology
R&D
Stem Cell
Extracellular Vesicle
Immune Cell
Genetic engineering+
Industrialization Center
Drug Pipeline
Clinical Translation
Research Services
Social Responsibility
Public Welfare
Green Production
Media Center
Company News
Video Center
Join Us
Cooperations
Investor Relations
Supplier Relationships
Join us
简体中文
Navigation Menu
Navigation Menu
Home
About
About Us
R&D Team
Quality System
Honors & Certifications
Patent & Technology
R&D
Stem Cell
Extracellular Vesicle
Immune Cell
Genetic engineering+
Industrialization Center
Drug Pipeline
Clinical Translation
Research Services
Social Responsibility
Public Welfare
Green Production
Media Center
Company News
Video Center
Join Us
Cooperations
Investor Relations
Supplier Relationships
Join us
简体中文
Media Center
Witnessing every breakthrough of Wingor Biotech in the field of cell and gene therapy, and conveying its innovative commitment to safeguarding life and health.
Company News
Video Center
Company News
Video Center
喜报|茵冠生物第八款干细胞新药IND获受理!
2026年8月26日
2036
喜报!茵冠生物第三款干细胞新药获批临床试验!
2026年1月16日
12695
喜报 | 茵冠生物参与的「脑卒中干细胞超微创递送技术及器械研究」获2026年度深医专项资金拟资助
2026年9月2日
1313
科技创新 | 茵冠生物“一种预处理间充质干细胞的方法和产品在脑卒中药物中的应用”获国家发明专利
2026年8月18日
3300
再传喜讯 | 茵冠生物人脐带间充质干细胞主细胞库获FDA Master File备案
2026年8月17日
3180
上一页
1
2
3
…
52
下一页